Dr Amir Gander is the Director of Tissue Access for Patient Benefit (TAPb), a group that facilitates research focused on use of human biological samples and non-interventional clinical trials. Having worked in industry to develop new medicinal products, Amir is one of the founding members of TAPb within the Royal Free and UCL. He also leads the UKCRC Tissue Directory and Coordination Centre, which is a national and international research infrastructure that brings together large patient cohorts, human biological samples clinical data and researchers across the world.